Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy (vol 59, pg 83, 2003)

被引:0
|
作者
Onozato, ML [1 ]
Tojo, A [1 ]
Goto, A [1 ]
Fujita, T [1 ]
机构
[1] Univ Tokyo, Dept Internal Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan
关键词
D O I
10.1016/S0168-8227(03)00086-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:217 / 217
页数:1
相关论文
共 50 条
  • [1] Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy
    Onozato, ML
    Tojo, A
    Goto, A
    Fujita, T
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 59 (02) : 83 - 92
  • [2] EFFECT OF DIPYRIDAMOLE ON PROTEINURIA OF DIABETIC NEPHROPATHY
    MAKINO, H
    OKADA, S
    OTA, Z
    CLINICAL NEPHROLOGY, 1983, 20 (03) : 160 - 161
  • [3] EFFECT OF COMBINATION THERAPY OF CAPTOPRIL AND DIPYRIDAMOLE ON PROTEINURIA IN PATIENTS WITH IGA NEPHROPATHY
    BANG, BK
    YANG, CW
    KIM, YS
    CHANG, YS
    YOON, YS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 346 - 346
  • [4] EFFECT OF DIPYRIDAMOLE (DP) ON DIABETIC NEPHROPATHY (DN)
    DEBERMUDEZ, LG
    BERMUDEZ, FJ
    KIDNEY INTERNATIONAL, 1985, 27 (01) : 136 - 136
  • [5] Combination therapy for the treatment of diabetic nephropathy
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (02) : 121 - 121
  • [6] Nephroprotective role of dipyridamole in diabetic nephropathy: Effect on inflammation and apoptosis
    Elsherbiny, Nehal M.
    Al-Gayyar, Mohammed M. H.
    Abd El Galil, Khaled H.
    LIFE SCIENCES, 2015, 143 : 8 - 17
  • [7] Additives annual (vol 59, pg 31, 2003)
    不详
    PLASTICS ENGINEERING, 2004, 60 (02) : 6 - 6
  • [8] Human recombinant ACE2 reduces the progression of diabetic nephropathy (vol 59, pg 529, 2010)
    Oudit, G. Y.
    Liu, G. C.
    Zhong, J.
    Basu, R.
    Chow, F. L.
    Zhou, J.
    Loibner, H.
    Janzek, E.
    Schuster, M.
    Penninger, J. M.
    Herzenberg, A. M.
    Kassiri, Z.
    Scholey, J. W.
    DIABETES, 2010, 59 (04) : 1113 - 1114
  • [9] Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT
    Shima, Yuko
    Nakanishi, Koichi
    Kaku, Yoshitsugu
    Ishikura, Kenji
    Hataya, Hiroshi
    Matsuyama, Takeshi
    Honda, Masataka
    Sako, Mayumi
    Nozu, Kandai
    Tanaka, Ryojiro
    Iijima, Kazumoto
    Yoshikawa, Norishige
    PEDIATRIC NEPHROLOGY, 2018, 33 (11) : 2103 - 2112
  • [10] Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT
    Yuko Shima
    Koichi Nakanishi
    Yoshitsugu Kaku
    Kenji Ishikura
    Hiroshi Hataya
    Takeshi Matsuyama
    Masataka Honda
    Mayumi Sako
    Kandai Nozu
    Ryojiro Tanaka
    Kazumoto Iijima
    Norishige Yoshikawa
    Pediatric Nephrology, 2018, 33 : 2103 - 2112